https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42037 Wed 17 Aug 2022 12:13:25 AEST ]]> Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47089 Wed 14 Dec 2022 09:30:29 AEDT ]]> Laxative use in inpatients on oxycodone/naloxone prolonged release and oxycodone prolonged release for cancer and non-cancer pain https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35390 Tue 23 Jul 2019 11:57:18 AEST ]]> Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23860 Sat 24 Mar 2018 07:12:11 AEDT ]]> Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44538 Mon 17 Oct 2022 09:03:29 AEDT ]]> Opioid poisoning in Newcastle over the last three decades: From heroin to prescription opioids https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53531 Mon 04 Dec 2023 15:38:31 AEDT ]]>